The U.S. Food and Drug Administration banned imports from one of the plants of Indian drug maker Wockhardt, in the latest example of increased global scrutiny of Indian generic drug makers.
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304747004579223811724316666.html?mod=pls_whats_news_us_business_f
via IFTTT
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304747004579223811724316666.html?mod=pls_whats_news_us_business_f
via IFTTT
No comments:
Post a Comment